Aisling Capital’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-50,857
| Closed | -$4.95M | – | 11 |
|
|
2017
Q4 | $4.95M | Hold |
50,857
| – | – | 0.98% | 8 |
|
|
2017
Q3 | $7.49M | Hold |
50,857
| – | – | 1.23% | 10 |
|
|
2017
Q2 | $8.18M | Hold |
50,857
| – | – | 1.4% | 8 |
|
|
2017
Q1 | $8.1M | Hold |
50,857
| – | – | 1.47% | 11 |
|
|
2016
Q4 | $6.18M | Hold |
50,857
| – | – | 1.44% | 13 |
|
|
2016
Q3 | $7.05M | Sell |
50,857
-40,000
| -44% | -$5.55M | 1.45% | 14 |
|
|
2016
Q2 | $16.5M | Buy |
+90,857
| New | +$16.5M | 3.89% | 11 |
|